The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and economic burden among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) receiving first-line (1L) chemoimmunotherapy (CIT) by risk status: A chart-linked claims analysis.
 
Lori A. Leslie
Honoraria - Abbvie/Pharmacyclics; ADC Therapeutics; BeiGene; Celgene; Janssen; Kite/Gilead; Seagen
Consulting or Advisory Role - Abbvie/Pharmacyclics; ADC Therapeutics; BeiGene; Celgene; Janssen; Kite/Gilead; Seagen
Speakers' Bureau - Abbvie/Pharmacyclics; ADC Therapeutics; BeiGene; Celgene; Janssen; Kite/Gilead; Seagen
 
Nilesh Gangan
Employment - HealthCore
Research Funding - Janssen Scientific Affairs (Inst)
 
Hiangkiat Tan
Employment - HealthCore
Stock and Other Ownership Interests - Anthem
 
Qing Huang
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Johnson & Johnson/Janssen